Back
Trevi Therapeutics Stock Price Chart
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
74
TRVI
Trevi Therapeutics
Last Price:
$6.58
Seasonality Move:
16.12%
7 Day Trial
ALL ACCESS PASS
$
7
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRVI is experiencing slight buying pressure.
Trevi Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.55 | Sell |
| 20-day SMA: | 5.47 | Buy |
| 50-day SMA: | 4.6 | Buy |
| 200-day SMA: | 3.44 | Buy |
| 8-day EMA: | 6.35 | Buy |
| 20-day EMA: | 5.71 | Buy |
| 50-day EMA: | 4.88 | Buy |
| 200-day EMA: | 3.68 | Buy |
Trevi Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 67.49 | Buy |
| Chaikin Money Flow: | 234244 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.19 - 6.29) | Buy |
| Bollinger Bands (100): | (2.9 - 5) | Buy |
Trevi Therapeutics Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Trevi Therapeutics Stock
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 6.40 while TRVI 8-day simple moving average is 6.55, which is a Sell signal.
-
The stock price of TRVI is 6.40 while Trevi Therapeutics 20-day SMA is 5.47, which makes it a Buy.
-
Trevi Therapeutics 50-day simple moving average is 4.60 while TRVI share price is 6.40, making it a Buy technically.
-
TRVI stock price is 6.40 and Trevi Therapeutics 200-day simple moving average is 3.44, creating a Buy signal.
TRVI Technical Analysis vs Fundamental Analysis
Buy
74
Trevi Therapeutics (TRVI)
is a Buy
Is Trevi Therapeutics a Buy or a Sell?
-
Trevi Therapeutics stock is rated a BuyThe current Trevi Therapeutics [TRVI] share price is $6.40. The Score for TRVI is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
Trevi Therapeutics Stock Info
Market Cap:
618.8M
Price in USD:
6.40
Share Volume:
1.2M
Trevi Therapeutics 52-Week Range
52-Week High:
7.39
52-Week Low:
2.30
Buy
74
Trevi Therapeutics (TRVI)
is a Buy
Trevi Therapeutics Share Price Forecast
-
What is the Trevi Therapeutics stock price today?The Trevi Therapeutics stock price is 6.40 USD today.
-
Will TRVI stock go up or go down?Trevi Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Trevi Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Trevi Therapeutics is not overvalued.
Is Trevi Therapeutics Stock a Buy?
-
Trevi Therapeutics share price is 6.40 while TRVI 8-day exponential moving average is 6.35, which is a Buy signal.
-
The stock price of TRVI is 6.40 while Trevi Therapeutics 20-day EMA is 5.71, which makes it a Buy.
-
Trevi Therapeutics 50-day exponential moving average is 4.88 while TRVI share price is 6.40, making it a Buy technically.
-
TRVI stock price is 6.40 and Trevi Therapeutics 200-day simple moving average is 3.68, creating a Buy signal.
Fundamental Analysis of Trevi Therapeutics
Is Trevi Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Trevi Therapeutics
Should I short Trevi Therapeutics stock?
-
TRVI Moving Average Covergence Divergence (MACD) indicator is 0.64, suggesting Trevi Therapeutics is a Buy
-
Trevi Therapeutics Relative Strength Index (RSI) is 67.49, which suggest Trevi Therapeutics is overbought
-
The Bollinger Bands (25) for Trevi Therapeutics is (4.19 - 6.29), which suggest Trevi Therapeutics is a Buy
-
The Bollinger Bands (100) for Trevi Therapeutics is (2.9 - 5), which suggest Trevi Therapeutics is a Buy
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.